Editas Medicine Inc
General ticker "EDIT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $158.1M
Editas Medicine Inc does not follow the US Stock Market performance with the rate: -31.9%.
Estimated limits based on current volatility of 7.0%: low 1.22$, high 1.40$
Factors to consider:
- Current price 80.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.80$, 15.20$]
- 2024-12-30 to 2025-12-30 estimated range: [8.17$, 17.05$]
Financial Metrics affecting the EDIT estimates:
- Negative: Non-GAAP EPS, $ of -2.05 <= 0.10
- Negative: Operating profit margin, % of -68.41 <= 1.03
- Negative: Operating cash flow per share per price, % of -14.06 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating profit margin (median), % of -98.30 <= 2.14
Short-term EDIT quotes
Long-term EDIT plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $25.54MM | $19.71MM | $78.12MM |
Operating Expenses | $218.69MM | $245.66MM | $247.30MM |
Operating Income | $-193.15MM | $-225.95MM | $-169.18MM |
Non-Operating Income | $0.64MM | $5.52MM | $15.96MM |
Interest Expense | $0.00MM | $4.22MM | $0.00MM |
R&D Expense | $142.51MM | $174.96MM | $177.65MM |
Income(Loss) | $-192.50MM | $-220.43MM | $-153.22MM |
Profit(Loss) | $-192.50MM | $-220.43MM | $-153.22MM |
Stockholders Equity | $553.64MM | $360.68MM | $349.10MM |
Inventory | $120.07MM | $93.10MM | $0.00MM |
Assets | $677.48MM | $514.32MM | $499.15MM |
Operating Cash Flow | $-163.80MM | $-177.35MM | $-132.18MM |
Capital expenditure | $7.98MM | $4.12MM | $4.72MM |
Investing Cash Flow | $-54.47MM | $114.07MM | $-3.73MM |
Financing Cash Flow | $282.11MM | $1.28MM | $118.04MM |
Earnings Per Share* | $-2.74 | $-2.98 | $-2.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.